Eli Lilly Stock Hits All-Time High Amid Positive Outlook from Analyst
Eli Lilly (LLY) stock reached a new all-time high as an analyst declared the company a 'clear winner' at an American Diabetes Association conference focused on weight-loss drugs. Novo Nordisk's chief scientist, however, expressed disagreement with this assessment.
Topics: Diabetes conference Pharmaceuticals Weight-loss drugs